For a full list of publications please see GoogleScholar. Recent highlights are listed here.

2024

Predicting Pseudomonas aeruginosa drug resistance using artificial intelligence and clinical MALDI–TOF mass spectra.

Nguyen HA, Peleg AY, Song J, Antony B, Webb GI, Wisniewski JA, Blakeway LV, Badoordeen GZ, Theegala R, Zisis H, Dowe DL, Macesic N. mSystems. 2024 Sep 17;9(9):e0078924.

2023

Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer.

Macesic N, Hawkey J, Vezina B, Wisniewski JA, Cottingham H, Blakeway LV, et al. Nat Commun. 2023;14(1):4764.

Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic review.

Liu AJ, Dennis ASM, Fariha Z, Pai Mangalore R, Macesic N. JAC Antimicrob Resist. 2024 Oct 9;6(5):dlae152.

EHR-ML: A generalisable pipeline for reproducible clinical outcomes using electronic health records.

Ramakrishnaiah Y, Macesic N, Webb GI, et al. medRxiv. 2024;2024.03.02.24302664.

EHR-QC: A streamlined pipeline for automated electronic health records standardisation and preprocessing to predict clinical outcomes.

Ramakrishnaiah Y, Macesic N, Webb GI, Peleg AY, Tyagi S. J Biomed Inform. 2023;147:104509.

Genomic investigation of multispecies and multivariant blaNDM outbreak reveals key role of horizontal plasmid transmission.

Macesic N, Dennis A, Hawkey J, Vezina B, Wisniewski JA, Cottingham H, et al. Infect Control Hosp Epidemiol. 2024 Jun;45(6):709-716.

Targeted sequencing of Enterobacterales bacteria using CRISPR-Cas9 enrichment and Oxford Nanopore Technologies.

Cottingham H, Judd, L, Wisniewski JA, et al. bioRxiv. 2024;2024.06.26.600727.

2025

Multidrug-resistant Gram-negative bacterial infections.

Macesic, N, Uhlemann AC, Peleg AY.
The Lancet. 2025 Jan 18;405(10474):257-272.